Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of durvalumab and lurbinectedin for relapsed or refractory small cell lung cancer; the stu…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial [Phase 3]
This clinical trials entry describes a Phase III randomized trial evaluating dose-escalation radiotherapy for limited-stage small cell lung …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy [Phase 1]
Phase 1 study update (DAREON-9) evaluating tolerability of varying doses of BI 764532 in combination with a single-agent chemotherapy in sma…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
EMA approval · 2026-03-30EMA Authorised: Tecentriq (atezolizumab) — Roche Registration GmbH
The European Medicines Agency authorized Tecentriq (atezolizumab) by Roche Registration GmbH for multiple cancer indications, including non-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study [Phase 2]
Phase 2 PRISM trial uses biomarker tests to guide selection of personalized therapies for extensive-stage small cell lung cancer; currently …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy [NA]
This completed clinical trial evaluated multidisciplinary-team-based nursing for patients with small cell lung cancer during chemo-immunothe…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy [Phase 1]
Phase 1 trial update evaluating Debio 0123 in combination with carboplatin and etoposide in adults with small cell lung cancer that recurred…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Phase 2 Study of Fingolimod in Lung Cancers [Phase 2]
Phase 2 clinical trial evaluating Fingolimod in non-small cell lung cancer and small-cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Study of Trilaciclib and Lurbinectidin [Phase 2]
A Phase 2 clinical trial evaluating the combination of trilaciclib and lurbinectedin for lung cancer, including small cell lung cancer, is c…
-
EMA approval · 2026-03-27New treatment for relapsed extensive-stage small cell lung cancer
The European Medicines Agency announces Imdylltra as a new treatment for relapsed extensive-stage small cell lung cancer, addressing an unme…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating Nanrilkefusp alfa alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the study (NCT04…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection [Phase 2]
Phase 2 trial assessing the imaging tracer 18F-FAPI-74 for cancer detection across multiple indications; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance [NA]
Massachusetts General Hospital reports an update on the Transitions Project, a study to support adults moving from cancer treatment to surve…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Durvalumab as Consolidation for Patients LS-SCLC [Phase 2]
Durvalumab is being studied as consolidation therapy for limited-stage small cell lung cancer in a Phase 2 trial. The study is currently rec…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Hospital-at-Home for People Receiving Tarlatamab [NA]
This clinical trial update notes that a hospital-at-home study is evaluating care for patients with small cell lung cancer who are receiving…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer [Phase 1]
Legend Biotech is conducting a Phase 1 trial of DLL3-directed CAR T-cells for extensive-stage small cell lung cancer, with inclusion of larg…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors [Phase 1]
Phase I study of [225Ac]Ac-ETN029 for DLL3-expressing advanced solid tumors is currently recruiting, sponsored by Novartis Pharmaceuticals.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of cabozantinib (XL184) and nivolumab in patients with various advanced cancers …
-
CLINICAL_TRIALS other · 2026-03-18Clinical Trial Update: Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) [Phase 1, Phase 2]
This clinical trial update describes an adaptive Phase 1/2 study evaluating dual-target CAR-NK cells in relapsed/refractory small cell lung …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors [Phase 1]
Phase 1 clinical trial update for AVA6103 in patients with locally advanced or metastatic selected solid tumors; the study is currently recr…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers [Phase 1, Phase 2]
A Phase 1/2 trial evaluating lurbinectedin in combination with berzosertib (an ATR kinase inhibitor) for small cell cancers and high-grade n…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression [Phase 2]
Phase 2 clinical trial evaluating limertinib in combination with carboplatin and etoposide for EGFR-mutant non-small cell lung cancer with t…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating trilaciclib to prevent myelosuppression in limited-stage small cell lung cancer; status shows not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: SYS6090 Combination Therapy in Advanced Lung Cancer [Phase 1, Phase 2]
Clinical trial update for SYS6090 combination therapy in advanced lung cancer, covering Phase 1 and Phase 2 studies; currently not yet recru…